07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
Cidara Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/02/2025
3:32 PM | Cidara Therapeutics (Subject)
Commodore Capital LP (Filed by)
| Form SCHEDULE 13G | |
06/30/2025
4:05 PM | Cidara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
06/25/2025
3:35 PM | Cidara Therapeutics (Filer)
| Form 424B5 | |
06/25/2025
3:39 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
4:18 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
4:30 PM | Cidara Therapeutics (Filer)
| Form 424B5 | |
06/23/2025
6:05 AM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2025
3:37 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
4:20 PM | Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
11:15 PM | Cidara Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for CDTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
4:47 PM | Cidara Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
7:31 AM | Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
7:37 PM | Cidara Therapeutics (Issuer)
Davarpanah Nicole Negar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/12/2025
7:40 PM | Cidara Therapeutics (Issuer)
Davarpanah Nicole Negar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
8:04 AM | Adage Capital Management, L.P. (Filed by)
Cidara Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/08/2025
4:25 PM | Cidara Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/15/2025
4:27 PM | Cidara Therapeutics (Filer)
| Form PRE 14A | |
04/02/2025
5:27 PM | Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:28 PM | Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
5:34 PM | Cidara Therapeutics (Issuer)
Ward Shane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
5:33 PM | Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:40 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
3:52 PM | Cidara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
5:31 PM | Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
5:24 PM | Cidara Therapeutics (Issuer)
KARBE FRANK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
5:29 PM | Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
5:38 PM | Cidara Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:42 PM | Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:02 PM | Cidara Therapeutics (Filer)
| Form 424B3 | |
01/01/2025
11:15 PM | Cidara Therapeutics (Filer)
| Form EFFECT | |
12/23/2024
3:39 PM | Cidara Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2024
5:15 PM | Canale-Theakston Carin (Reporting)
Cidara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:17 PM | Bassler Bonnie L (Reporting)
Cidara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:18 PM | Cidara Therapeutics (Issuer)
Mineo Chrysa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:19 PM | Cidara Therapeutics (Issuer)
Schroeder Theodore R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:20 PM | BURGESS DANIEL D (Reporting)
Cidara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:37 PM | Cidara Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
12/03/2024
3:34 PM | Cidara Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
11/29/2024
3:15 PM | Cidara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
11/26/2024
4:32 PM | Cidara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
10/02/2024
4:19 PM | Cidara Therapeutics (Issuer)
Shah Preetam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:25 PM | Cidara Therapeutics (Issuer)
Stein Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:27 PM | Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:30 PM | Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
7:10 AM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
5:26 PM | Cidara Therapeutics (Issuer)
Tari Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:27 PM | Cidara Therapeutics (Issuer)
Sandison Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:18 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:35 PM | Cidara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/13/2024
3:19 PM | Cidara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:15 PM | Cidara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Free CDTX Stock Alerts